177 related articles for article (PubMed ID: 23294897)
1. Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.
Massilamany C; Gangaplara A; Kim H; Stanford C; Rathnaiah G; Steffen D; Lee J; Reddy J
J Neuroimmunol; 2013 Mar; 256(1-2):19-27. PubMed ID: 23294897
[TBL] [Abstract][Full Text] [Related]
2. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
3. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
4. Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
Ueno R; Miyamoto K; Tanaka N; Moriguchi K; Kadomatsu K; Kusunoki S
J Neurosci Res; 2015 Dec; 93(12):1874-80. PubMed ID: 26340909
[TBL] [Abstract][Full Text] [Related]
5. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
[TBL] [Abstract][Full Text] [Related]
6. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
Stephenson EL; Mishra MK; Moussienko D; Laflamme N; Rivest S; Ling CC; Yong VW
Brain; 2018 Apr; 141(4):1094-1110. PubMed ID: 29506186
[TBL] [Abstract][Full Text] [Related]
8. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
9. Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
Zanucoli F; Thomé R; Bonfanti AP; de Carvalho AC; Issayama LK; da Costa TA; Di Gangi R; Ferreira IT; Bombeiro AL; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2014 Dec; 20(12):1061-4. PubMed ID: 25417930
[No Abstract] [Full Text] [Related]
10. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
[TBL] [Abstract][Full Text] [Related]
11. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Xie C; Ciric B; Yu S; Zhang GX; Rostami A
J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Frezel N; Sohet F; Daneman R; Basbaum AI; Braz JM
Exp Neurol; 2016 Sep; 283(Pt A):224-34. PubMed ID: 27343802
[TBL] [Abstract][Full Text] [Related]
14. Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.
McDonald CA; Payne NL; Sun G; Clayton DJ; Del Borgo MP; Aguilar MI; Perlmutter P; Bernard CC
J Neuroimmunol; 2014 Dec; 277(1-2):67-76. PubMed ID: 25454728
[TBL] [Abstract][Full Text] [Related]
15. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
16. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
[TBL] [Abstract][Full Text] [Related]
17. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
18. Voluntary wheel running differentially affects disease outcomes in male and female mice with experimental autoimmune encephalomyelitis.
Mifflin KA; Frieser E; Benson C; Baker G; Kerr BJ
J Neuroimmunol; 2017 Apr; 305():135-144. PubMed ID: 28284334
[TBL] [Abstract][Full Text] [Related]
19. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
[TBL] [Abstract][Full Text] [Related]
20. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
